| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 492 | 2019 |
| Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2 … AJ Garber, AB King, S Del Prato, S Sreenan, MK Balci, M Muñoz-Torres, ... The Lancet 379 (9825), 1498-1507, 2012 | 454 | 2012 |
| Troglitazone action is independent of adipose tissue. CF Burant, S Sreenan, K Hirano, TA Tai, J Lohmiller, J Lukens, ... The Journal of clinical investigation 100 (11), 2900-2908, 1997 | 422 | 1997 |
| Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. M Pontoglio, S Sreenan, M Roe, W Pugh, D Ostrega, A Doyen, AJ Pick, ... The Journal of clinical investigation 101 (10), 2215-2222, 1998 | 405 | 1998 |
| Visualizing superoxide production in normal and diabetic rat islets of Langerhans VP Bindokas, A Kuznetsov, S Sreenan, KS Polonsky, MW Roe, ... Journal of Biological Chemistry 278 (11), 9796-9801, 2003 | 287 | 2003 |
| Increased beta-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. S Sreenan, AJ Pick, M Levisetti, AC Baldwin, W Pugh, KS Polonsky Diabetes 48 (5), 989-996, 1999 | 229 | 1999 |
| What’s distressing about having type 1 diabetes? A qualitative study of young adults’ perspectives M Balfe, F Doyle, D Smith, S Sreenan, R Brugha, D Hevey, R Conroy BMC endocrine disorders 13, 1-14, 2013 | 225 | 2013 |
| Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice ID Dukes, S Sreenan, MW Roe, M Levisetti, YP Zhou, D Ostrega, GI Bell, ... Journal of Biological Chemistry 273 (38), 24457-24464, 1998 | 220 | 1998 |
| Calpains play a role in insulin secretion and action SK Sreenan, YP Zhou, K Otani, PA Hansen, KPM Currie, CY Pan, JP Lee, ... Diabetes 50 (9), 2013-2020, 2001 | 218 | 2001 |
| Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone S Sreenan, J Sturis, W Pugh, CF Burant, KS Polonsky American Journal of Physiology-Endocrinology and Metabolism 271 (4), E742-E747, 1996 | 190 | 1996 |
| A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin KY Seong, MS Seo, DY Hwang, ED O'Cearbhaill, S Sreenan, JM Karp, ... Journal of Controlled Release 265, 48-56, 2017 | 149 | 2017 |
| Efficacy and safety comparison between the DPP-4 inhibitor vildagliptin and the sulfonylurea gliclazide after two years of monotherapy in drug-naive patients with type 2 diabetes JE Foley, S Sreenan Hormone and Metabolic Research 41 (12), 905-909, 2009 | 141 | 2009 |
| Barriers to exercise in obese patients with type 2 diabetes AM Egan, WAW Mahmood, R Fenton, N Redziniak, T Kyaw Tun, ... QJM: An International Journal of Medicine 106 (7), 635-638, 2013 | 126 | 2013 |
| PREDICTIVE™–a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia … HJ Lüddeke, S Sreenan, S Aczel, S Maxeiner, M Yenigun, P Kozlovski, ... Diabetes, Obesity and Metabolism 9 (3), 428-434, 2007 | 125 | 2007 |
| Safety and efficacy of insulin detemir in clinical practice: 14‐week follow‐up data from type 1 and type 2 diabetes patients in the PREDICTIVETM European cohort A Dornhorst, HJ Lüddeke, S Sreenan, C Koenen, JB Hansen, A Tsur, ... International journal of clinical practice 61 (3), 523-528, 2007 | 124 | 2007 |
| Thyroid dysfunction is not associated with alterations in serum leptin levels S Sreenan, JF Caro, S Refetoff Thyroid 7 (3), 407-409, 1997 | 118 | 1997 |
| Insulin detemir improves glycaemic control without weight gain in insulin‐naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study A Dornhorst, HJ Lüddeke, S Sreenan, P Kozlovski, JB Hansen, BJ Looij, ... International journal of clinical practice 62 (4), 659-665, 2008 | 106 | 2008 |
| Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal‐only therapy with oral antidiabetic drugs improves glycaemic control … A Dornhorst, HJ Lüddeke, C Koenen, M Meriläinen, A King, A Robinson, ... Diabetes, Obesity and Metabolism 10 (1), 75-81, 2008 | 96 | 2008 |
| Immunological/physiological relationships in asthma: potential regulation by lung macrophages LW Poulter, G Janossy, C Power, S Sreenan, C Burke Immunology today 15 (6), 258-261, 1994 | 96 | 1994 |
| Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled … M von Herrath, SC Bain, B Bode, JO Clausen, K Coppieters, L Gaysina, ... The Lancet Diabetes & Endocrinology 9 (4), 212-224, 2021 | 89 | 2021 |
